U.S. Global Investors, Inc. (GROW) - 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended December 31, 2025, and the six months ended December 31, 2025. U.S. Global Investors, Inc. operates two primary segments: Investment Management Services (advising ETFs and mutual funds) and Corporate Investments (investing for its own account). The company is a non-accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Six Months Ended Dec 31, 2025 | Three Months Ended Dec 31, 2025 |
|---|---|---|
| Total Operating Revenues | $4.76 million | $2.51 million |
| Net Investment Income (Loss) | $2.82 million | $0.54 million |
| Net Income (Loss) | $0.66 million | $(0.85) million |
| Diluted EPS | $0.05 | $(0.07) |
| Cash and Cash Equivalents | $25.23 million | $25.23 million (Balance Sheet) |
| Total Assets | $47.22 million | $47.22 million (Balance Sheet) |
| Shareholders' Equity | $44.17 million | $44.17 million (Balance Sheet) |
| Long-Term Debt | $0.08 million (Notes Payable) | $0.08 million (Notes Payable) |
Note: The company has a $1.0 million unutilized credit facility.
Material Changes vs. Prior Period
- Revenue Growth: Operating revenues increased 8.5% year-over-year for the six-month period, driven by a $735,000 increase in USGIF advisory fees due to higher average assets under management (AUM), offsetting a $555,000 decrease in ETF fees.
- Profitability Volatility: While the six-month period showed a net income of $0.66 million (up from $0.23 million in the prior year), the third quarter resulted in a net loss of $0.85 million. This quarterly loss was primarily driven by a discrete tax expense of $1.38 million related to the tax treatment of HIVE convertible securities.
- Investment Performance: Net investment income surged to $2.82 million for the six months (vs. $1.27 million prior year), largely due to $1.9 million in unrealized gains on trading securities, including $1.3 million recognized under the measurement alternative for equity securities.
- Expense Management: Operating expenses decreased 2.2% year-over-year for the six-month period, primarily due to a $298,000 reduction in general and administrative expenses related to lower ETF costs.
Guidance, Outlook, and Risks
- Tax Accounting Change: Subsequent to the period end, the company filed a Form 3115 to change its tax accounting method regarding HIVE convertible securities. Management expects to record an offsetting tax benefit of approximately $1.3 million in the quarter ending March 31, 2026.
- Dividends: The Board authorized a monthly dividend of $0.0075 per share through March 2026. Total expected payments for Q1 2026 are approximately $287,000.
- Share Repurchases: The company repurchased 421,269 shares for $1.1 million during the six months ended December 31, 2025. The annual repurchase authorization for 2025 was $5.0 million.
- Risk Factors: Significant exposure to market volatility, particularly in cryptocurrency-related assets (indirect exposure via ETFs and mining companies) and foreign currency fluctuations. A hypothetical 25% decrease in equity prices would reduce net income by approximately $2.55 million.
Investor Verification Checklist
- Tax Provision Impact: Verify the timing and magnitude of the expected $1.3 million tax benefit in Q1 2026 related to the HIVE securities accounting method change.
- Investment Valuation: Review the $1.3 million unrealized gain recognized under the measurement alternative for equity securities without readily determinable fair values to understand the underlying observable price changes.
- AUM Trends: Monitor the divergence between period-end AUM (up $221.6 million) and average AUM (down $49.3 million year-over-year) to assess fee revenue sustainability.
- Cryptocurrency Exposure: Assess the concentration of assets in crypto-related ETFs and the associated volatility risks disclosed in the market risk section.